PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
53.94
ESG score 80-90% of RIGL's 61.39. Walter Schloss would scrutinize governance quality and regulatory exposure.
52.44
Environmental score 80-90% of RIGL's 58.49. Walter Schloss would scrutinize carbon exposure and transition planning.
56.52
Social score 90-95% of RIGL's 61.73. Bill Ackman would demand clear social improvement catalysts.
52.86
Governance score 80-90% of RIGL's 63.96. Walter Schloss would scrutinize management accountability and board independence.